thank you
Your email has been sent.
217 Promenade Way - Building 2 1,250 SF Office/Medical Condo Units in Sugar Land, TX 77478
INVESTMENT HIGHLIGHTS
- Condo units may be combined
- Construction to begin early 2025
PROPERTY FACTS
| Total Building Size | 5,000 SF | Typical Floor Size | 5,000 SF |
| Property Type | Office | Year Built | 2025 |
| Property Subtype | Medical | Lot Size | 3.66 AC |
| Building Class | B | Parking Ratio | 4/1,000 SF |
| Floors | 1 | ||
| Zoning | PD - Planned Development | ||
| Total Building Size | 5,000 SF |
| Property Type | Office |
| Property Subtype | Medical |
| Building Class | B |
| Floors | 1 |
| Typical Floor Size | 5,000 SF |
| Year Built | 2025 |
| Lot Size | 3.66 AC |
| Parking Ratio | 4/1,000 SF |
| Zoning | PD - Planned Development |
AMENITIES
- Signage
4 UNITS AVAILABLE
Unit 100
| Unit Size | 1,250 SF | Sale Type | Owner User |
| Condo Use | Office/Medical |
| Unit Size | 1,250 SF |
| Condo Use | Office/Medical |
| Sale Type | Owner User |
DESCRIPTION
Building 2, Unit 100 of Phase I
SALE NOTES
Building 2, Unit 100 of Phase I
Unit 200
| Unit Size | 1,250 SF | Sale Type | Owner User |
| Condo Use | Office/Medical |
| Unit Size | 1,250 SF |
| Condo Use | Office/Medical |
| Sale Type | Owner User |
DESCRIPTION
Building 2, Unit 200 of Phase I
SALE NOTES
Building 2, Unit 200 of Phase I
Unit 300
| Unit Size | 1,250 SF | Sale Type | Owner User |
| Condo Use | Office/Medical |
| Unit Size | 1,250 SF |
| Condo Use | Office/Medical |
| Sale Type | Owner User |
DESCRIPTION
Building 2, Unit 300 of Phase I
SALE NOTES
Building 2, Unit 300 of Phase I
Unit 400
| Unit Size | 1,250 SF | Sale Type | Owner User |
| Condo Use | Office/Medical |
| Unit Size | 1,250 SF |
| Condo Use | Office/Medical |
| Sale Type | Owner User |
DESCRIPTION
Building 2, Unit 400 of Phase I
SALE NOTES
Building 2, Unit 400 of Phase I
1 of 1
1 of 7
VIDEOS
3D TOUR
PHOTOS
STREET VIEW
STREET
MAP
1 of 1
Presented by
217 Promenade Way - Building 2
Hmm, there seems to have been an error sending your message. Please try again.
Thanks! Your message was sent.